PFS
KURA icon

Prospera Financial Services’s Kura Oncology KURA Stock Holding History

Prospera Financial Services’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-245
Closed -$4K – 1256
2022
Q2 		$4K Sell
245
-5,114
-95% -$73.6K ﹤0.01% 1480
2022
Q1 		$86K Buy
+5,359
New +$77.4K ﹤0.01% 1162

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Prospera Financial Services's KURA Position: Q3 2022 in Review

Prospera Financial Services sold out of Kura Oncology (KURA) in Q3 2022, closing a stake of 245 shares — an estimated $4K sold.

Prospera Financial Services first reported a position in KURA in Q1 2022 and held it in 2 quarters. The position peaked at $86K in Q1 2022. 148 funds tracked by Wall St. Rank hold KURA as of Q3 2022.

  • Prospera Financial Services reported no remaining Kura Oncology position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 245 Kura Oncology shares in Q3 2022, an estimated $4K.
  • Prospera Financial Services first reported a position in Kura Oncology in Q1 2022 and held it in 2 quarters.
  • Prospera Financial Services's Kura Oncology position peaked at $86K in Q1 2022.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.